dhpg was significantly more active than acyclovir against all but one ( mouse cytomegalovirus ) of the strains tested , with 50 % effective doses ranging from 5 to 13 microm , as determined by plaque reduction assays in human embryonic lung ( mrc-5 ) and human embryonic tonsil cells .
C0017066
dhpg
C0001367
acyclovir